Search research articles
Contact Us
Filters
Showing results (141-150 of 268) with videos related to
Page
of 27
Sort By:
Psychosomatic Medicine
|
September 1, 1984
Plasma cortisol and beta-endorphin immunoreactivity in human obesity
M R Cohen, D Pickar, R M Cohen, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
May 1, 1996
Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapine
R E Litman, T P Su, W Z Potter, et al.
The American Journal of Psychiatry
|
October 10, 1998
Dopamine D2 receptor density and personal detachment in healthy subjects
A Breier, L Kestler, C Adler, et al.
Neuropeptides
|
July 1, 1985
Hormonal effects of high dose naloxone in humans
M R Cohen, R M Cohen, D Pickar, et al.
Archives of General Psychiatry
|
May 1, 1992
Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine
D Pickar, R R Owen, R E Litman, et al.
JAMA
|
June 2, 1993
Neuropsychiatric effects of anabolic steroids in male normal volunteers
T P Su, M Pagliaro, P J Schmidt, et al.
The American Journal of Psychiatry
|
October 1, 1982
High plasma norepinephrine levels in patients with major affective disorder
C R Lake, D Pickar, M G Ziegler, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
September 1, 1993
Beneficial effects of nalmefene augmentation in neuroleptic-stabilized schizophrenic patients
M H Rapaport, O Wolkowitz, J R Kelsoe, et al.
Life Sciences
|
October 19, 1987
Prednisone decreases CSF somatostatin in healthy humans: implications for neuropsychiatric illness
O M Wolkowitz, D R Rubinow, A Breier, et al.
The American Journal of Psychiatry
|
November 1, 1991
Correlation of Wisconsin Card Sorting Test performance with eye tracking in schizophrenia
R E Litman, D W Hommer, T Clem, et al.
Page
of 27
Search research articles
Search
Showing results (141-150 of 268) with videos related to
Sort By:
Page
of 27
Psychosomatic Medicine
|
September 1, 1984
Plasma cortisol and beta-endorphin immunoreactivity in human obesity
M R Cohen, D Pickar, R M Cohen, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
May 1, 1996
Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapine
R E Litman, T P Su, W Z Potter, et al.
The American Journal of Psychiatry
|
October 10, 1998
Dopamine D2 receptor density and personal detachment in healthy subjects
A Breier, L Kestler, C Adler, et al.
Neuropeptides
|
July 1, 1985
Hormonal effects of high dose naloxone in humans
M R Cohen, R M Cohen, D Pickar, et al.
Archives of General Psychiatry
|
May 1, 1992
Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine
D Pickar, R R Owen, R E Litman, et al.
JAMA
|
June 2, 1993
Neuropsychiatric effects of anabolic steroids in male normal volunteers
T P Su, M Pagliaro, P J Schmidt, et al.
The American Journal of Psychiatry
|
October 1, 1982
High plasma norepinephrine levels in patients with major affective disorder
C R Lake, D Pickar, M G Ziegler, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
September 1, 1993
Beneficial effects of nalmefene augmentation in neuroleptic-stabilized schizophrenic patients
M H Rapaport, O Wolkowitz, J R Kelsoe, et al.
Life Sciences
|
October 19, 1987
Prednisone decreases CSF somatostatin in healthy humans: implications for neuropsychiatric illness
O M Wolkowitz, D R Rubinow, A Breier, et al.
The American Journal of Psychiatry
|
November 1, 1991
Correlation of Wisconsin Card Sorting Test performance with eye tracking in schizophrenia
R E Litman, D W Hommer, T Clem, et al.
Page
of 27